Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.
Journal: The New England journal of medicine
Published: June 03, 2024
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.
Journal: The New England journal of medicine
Published: June 03, 2024
Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 06, 2023
Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 06, 2021
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy.
Journal: Clinical endocrinology
Published: June 10, 2015
Lymphoma in acquired generalized lipodystrophy.
Journal: Leukemia & lymphoma
Published: April 14, 2015
The clinical approach to the detection of lipodystrophy - an AACE consensus statement.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: February 26, 2013
Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 10, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026